Walbro Engineering Manager, New Product Development Brad Roche joins host Tyler Kern to outline how the company is doing its part to assist medical personnel on the front lines of the battle against the global COVID-19 pandemic.
On this episode of Talking Shop with Walbro, host Tyler Kern was joined by Walbro Engineering Manager, New Product Development Brad Roche for a special discussion about how the company is helping those on the front lines of the fight against the COVID-19 pandemic.
Walbro has created an aerosol shield for nurse anesthetists and anesthesiologists to utilize during intubation, which protects these front-line healthcare workers from aerosol particles potentially spreading the novel coronavirus.
The product addresses a critical need for personal protective equipment, or PPE, that has been exposed by the accelerated spread of the virus.
“Through some brainstorming that we did, we tried to identify a lot of things that we could help with, then we started reaching out to medical professionals,” Roche said. “Through their guidance and feedback, we’ve created this device, which is largely based on something people are building in their garages. We thought we could bring a level of professionalism to it and make it a lot more durable, a lot more usable and (make it) last a lot longer for medical professionals.”
The entire process of engaging in this transition to supporting the medical community took less two weeks, with the initial brainstorm coming in mid-March, further consultation and improvements aimed at mass production toward the end of the month, and the first prototype-tooled version finalized on March 27.
Though Walbro was able to convert a plant typically manufacturing products like fuel tanks into a viable location for the production of these shields, Roche said the real heroes are those serving our global community on the leading edge of the fight against COVID-19. Learn more today at https://www.walbro.com/aerosol-shield/.
For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
Artificial intelligence has moved from novelty to necessity almost overnight. Since generative AI tools entered the mainstream just a few years ago, organizations across every industry have felt pressure to “do something” with AI—often before they fully understand what that something should be. Research shows that while most companies are experimenting with AI, very…
Supply chains are under pressure like never before—fuel prices are volatile, driver shortages persist, and new technologies are rewriting the rules in real time. In fact, at major U.S. truckload carriers, driver turnover has historically exceeded 90% annually—highlighting just how urgent it is to improve both efficiency and the driver experience. Trucking isn’t just…
Healthcare is being pushed to modernize faster than ever, as AI tools, virtual care, and digital patient experiences shift from innovation to expectation. Recent survey data from McKinsey & Company indicates that about half of U.S. healthcare leaders say their organizations have already put generative AI into practice, underscoring how quickly the technology is…
The U.S. healthcare system is under real strain—and it’s something both patients and physicians are feeling in everyday care. In Texas, those pressures are even more visible, where rapid population growth, rural access challenges, and regulatory complexity are making it harder for patients to get timely care and for doctors to focus on medicine…
Healthcare is being pushed to modernize faster than ever, as AI tools, virtual care, and digital patient experiences shift from innovation to expectation. Recent survey data from McKinsey & Company indicates that about half of U.S. healthcare leaders say their organizations have already put generative AI into practice, underscoring how quickly the technology is…
Heart disease remains the leading cause of death in the U.S., with 683,491 deaths reported in 2024, according to the CDC. As cardiovascular care shifts toward access, prevention, and value-based outcomes, noninvasive therapies are gaining renewed attention for patients who continue to experience symptoms after traditional interventions. At the same time, rising healthcare costs…
